Our objective is to identify quality value investment opportunities primed for growth, attracting additional high-quality institutional investors, forging partnerships, and building businesses that are highly likely to have positive value inflections, thereby creating extraordinary future value for our limited partners, shareholders and buyers.
Given this is a team sport, we can lead or join a syndicate to invest for growth. We are, however, open to being the sole, main investor.
David H. Crean, President and Chief Executive Officer
David has +25 years of experience as a strategic and financial advisor focused on M&A, investments, and partnering transactions with life science and healthcare companies. He holds FINRA Series 79 and Series 63 licenses and is a Registered Investment Banking Representative of BA Securities LLC, Member FINRA.
Todd S. Caven, General Partner
Todd has +30 years of experience in finance, taxation, mergers & acquisitions, and corporate valuations for both publicly traded and privately-held companies. Mr. Caven founded Rock Ridge Enterprises, a Minnesota-based PE firm, and Saguaro Capital Partners, a VC firm focused on life science and technology companies.
We are bold, innovative, and steeped in industry know-how, wise, experienced but not staid, professional but with the confidence to be casual, confident yet void of arrogance, discerning, driven by growth, proactive, and risk-takers grounded in science and data.
We represent innovation, scientific creativity, technological leadership, entrepreneurship, executive leadership, and professional capital management for your life sciences business.